ADVERTISEMENT
“It’s a very targeted and very effective treatment,” notes Marc Perrussel, who points out that if they are not as easily dispensed as other treatment options, it’s because they are very expensive. “That said, the National Drug Safety Authority is currently reviewing its approach to make these treatments more accessible,” he emphasizes.
Regarding psoriasis, we now know that the more these cells communicate over time, the more numerous they are and the more the disease becomes prevalent, as if the population of memory cells increases over the years, and the impact of the pathology with it. “Early treatment allows for better results, we can relieve patients by reducing the importance of their treatment over time, and limit the risks of progression to psoriatic arthritis, which is a debilitating comorbidity,” adds the dermatologist.
With this option, currently offered as a last resort, patients can see their quality of life improve like with no other treatment: “Before, the goal was to provide relief to the patient, explaining that they had a chronic illness that they would have to learn to live with over the long term. We prescribed medications that allowed 60% whitening, but it would eventually come back. Today, the goal, particularly with this type of drug approach, is to achieve total and lasting whitening.”
